Fibrous Matrix Coatings for Cardiac Pacing Leads
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional medical electrodes face challenges such as difficulty in controlling tissue ingrowth, inflammation, and reduced electrode performance over time due to polarization and fibrous scar tissue formation at the electrode/tissue interface, affecting the electrical performance of cardiac pacing leads.
Innovation Solution
A medical electrical lead with a fibrous matrix coating made from polyisobutylene urethane or urethane/urea copolymers, which improves abrasion resistance, electrical insulation, and controls tissue ingrowth by adjusting fiber diameter, spacing, and porosity, while maintaining impedance and pacing capability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional electrode materials are used, then electrical performance is maintained, but tissue in-growth control is difficult and fibrous scar tissue forms
Solution Approach 1:
The patent applies porous polymeric materials with controlled porosity (30-80%) to the electrode surface. The porous structure allows selective tissue interaction while maintaining electrical performance, preventing harmful fibrous scar tissue formation through controlled pore architecture that discourages uncontrolled tissue in-growth.
Solution Approach 2:
The patent uses composite polymeric materials combining different polymer components (e.g., polyisobutylene urethane, polyurea, or copolymers) with specific molecular weights and compositions. These composite materials provide both biocompatibility to reduce fibrous encapsulation and maintain electrical conductivity for reliable electrode function.
2Power
If electrode materials are used to stimulate heart tissue, then electrical energy is delivered, but polarization at the electrode/tissue interface occurs
Solution Approach 1:
The patent modifies the electrical and surface properties of the electrode by changing material parameters - using polymers with specific dielectric constants, surface energies, and electrical resistivities. These parameter changes reduce polarization effects at the electrode/tissue interface while maintaining effective electrical energy delivery for cardiac stimulation.
3Duration of action of stationary object
If medical leads are implanted long-term, then cardiac pacing function is provided, but lead extraction becomes difficult due to tissue ingrowth
Solution Approach 1:
The patent employs polymers with specific mechanical properties including elastomeric characteristics and controlled durometer hardness (20-80 Shore A). These dynamic mechanical properties allow the lead to accommodate tissue movement during implantation while maintaining a interface that facilitates easier extraction after the therapeutic period, reducing extraction difficulty through optimized material compliance.
4Object-generated harmful factors
If fibrous matrix coating is applied to control tissue ingrowth, then tissue in-growth is reduced, but manufacturing complexity increases
Solution Approach 1:
The patent applies fibrous matrix coating with specific fiber diameter ranges (1-100 micrometers) and controlled porosity (30-80%) only to specific portions of the lead where tissue interaction occurs. This localized application of complex coating structures minimizes overall device complexity while providing tissue in-growth control where most needed.
Data Source
Figure 1
Figure 2A~2B
Figure 3~4
AI summary
A medical electrical lead may include an insulative lead body, a conductor disposed within the insulative lead body, an electrode disposed on the insulative lead body and in electrical contact with the conductor and a fibrous matrix disposed at least partially over the electrode. The fibrous matrix may be formed from a polyisobutylene urethane, urea or urethane/urea copolymer.